x min read

BPS initiates coverage on Inergetics, Inc. (OTCMKTS:NRTI)

BPS initiates coverage on Inergetics, Inc. (OTCMKTS:NRTI)
Written by
Aaron Smith
Published on
October 28, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook

On 20th October’14, BrilliantPennyStocks.com initiated coverage on NRTI. The stock moved up by 0% since the coverage was initiated.

NEWARK, N.J headquartered nutritional supplements maker Inergetics, Inc. (OTCMKTS:NRTI) announced recently that it has scheduled a meeting of its entire Scientific/Medical Advisory Board on November 20, 2014. The meeting will be held either in San Francisco or Oakland.

The emergent meeting by the advisory board will tackle any last minute issues that might have cropped up with respect to the development of its patented “proprietary line of natural Cannabidiol (CBD)-based nutritional supplements”, as a marketable product. The cannabis based drug maker hopes to take the product into the market by mid 2015.

Role Of The Advisory Board

The advisory board will be reviewing the final product formulation ahead of submitting the same for commencement of manufacturing. Production would be followed by dispersal of the same in Medical Marijuana Dispensaries. The meeting was convened by Carl Germano, RD, CNS, CDN, who serves as the Chief Science Officer for Inergetics, Inc. (OTCMKTS:NRTI).

As part of the last state due diligence, the advisory board is expected to visit dispensaries and investigate how the drug extraction facility is currently occurring in the HEMP industry. Further, the advisory board is slated to give final touches to the “branding, packaging and marketing” of the finished product.

Key Board Members

He will be working in tandem with five other advisory board members to review the formulation. These members are Dr. Justin Fischedick, Dr. Joseph McSherry, Dr. Michelle Sexton, Dr. Yu Shao and Dr. Mark Wallace. They will in turn advise the company CEO Mike James and Chief Marketing Officer Jim Kras about the next steps that need to be followed in order to take the drug towards commercial sales.

CEO Speak

In the run up to the scheduled meeting next month, Inergetics, Inc. (OTCMKTS:NRTI) CEO Mike James has gone on record to state that,

"We are very excited to be entering the final stages of product development for our CBD line of nutritional supplements, beginning with our 'first to market' combination cannabinoid product."

Signup now to receive the next BPS alert by clicking HERE

About BrilliantPennyStocks

BSP provides sponsored and non-sponsored small cap and micro cap stock research reports, articles, daily stock market blogs, and popular investment newsletters. BPS provides alerts to investors and traders on stocks that could potentially breakout. To obtain text message stock alerts service, text the word Avauncer to 95577 from your cell phone. Additionally, BPS provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure: BrilliantPennyStocks is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://brilliantpennystocks.com/disclaimer/ for complete risks and disclosures.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.